No abstract available
MeSH terms
-
Aged
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / adverse effects*
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Bevacizumab
-
Carcinoma, Squamous Cell / complications
-
Carcinoma, Squamous Cell / drug therapy
-
Disease Progression
-
Doxorubicin / adverse effects
-
Doxorubicin / analogs & derivatives*
-
Drug Administration Schedule
-
Drug Resistance, Neoplasm
-
Female
-
Humans
-
Middle Aged
-
Ovarian Neoplasms / complications*
-
Ovarian Neoplasms / drug therapy*
-
Platinum Compounds / adverse effects
-
Polyethylene Glycols / adverse effects*
-
Recurrence
-
Renal Insufficiency / chemically induced
-
Renal Insufficiency / etiology*
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Platinum Compounds
-
liposomal doxorubicin
-
Bevacizumab
-
Polyethylene Glycols
-
Doxorubicin